Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2023-02-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring
NCT03977168
Development of a Pelvic Cavity Characterization Algorithm Through the Acquisition of MRI Images and Pressure Measurement by an Intravaginal Probe
NCT04319653
Dynamic Magnetic Resonance Imaging Before and After Vaginal Prolapse Repair
NCT03315715
MRI & MRV in Pelvic Congestion Syndrome in Females
NCT03252041
Dynamic MRI of the Behaviour of Female Pelvic Floor
NCT00747370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic Intervention
Pelvic Binder Radiography
One series of radiographic exposures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pelvic Binder Radiography
One series of radiographic exposures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute emergency department admission or transfer to Los Angeles County + USC Medical Center
* Presentation within 3 weeks of injury
* Blunt or blast mechanism of traumatic injury
* Lateral compression pelvic ring injury with unilateral incomplete disruption of the posterior arch (OTA/AO 61B1.1/2.2; Young Burgess LC1) on radiographs and/or computed tomography scan of the pelvis obtained per routine care
* LC1 pelvic ring injuries occurring in isolation are virtually never associated with hemodynamic instability or critical patient condition
* Stress examination of LC1 pelvic ring injury is standard of care
* Patient must speak either English or Spanish
Exclusion Criteria
* Volume expanding pelvic ring injury injuries represent the types of pelvic ring disruption responsible for pelvic hemorrhage and hypotension and are correlate with patient hemodynamic instability as well as critical injuries
* Volume expanding pelvic ring injury injuries warrant stabilization with circumferential pelvic compression.
* Patients with volume expanding pelvic ring injury are not clinically appropriate for this study.
* Hemodynamic instability or hypotension angioembolization (AE), preperitoneal pelvic packing (PPP), or Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) to obtain or maintain hemodynamic stability
* Bladder, vaginal, rectal, colonic, or other abdominal or pelvic organ injury precluding safe application of circumferential pelvic compression device
* Patient likely to have severe problems with maintaining follow- up due to at least one of the following:
* Patient has been diagnosed with a severe psychiatric condition
* Patient is intellectually challenged without adequate family support
* Patient lives outside the hospital's catchment area
* Follow-up is planned at another medical center
* Patients who are prisoners or homeless
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph Patterson
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph T Patterson, MD
Role: PRINCIPAL_INVESTIGATOR
Keck School of Medicine of the University of Southern California
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keck Medical Center of USC
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-22-00217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.